Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Nature Genetics|July 19, 2011
NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granulesMeral Gunay-Aygun, Tzipora C Falik-Zaccai, Thierry Vilboux, et al.
Blood Advances|December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristicsMehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working PartyAleksandar Radujkovic, Sascha Dietrich, Henric-Jan Blok, et al.
Hemasphere|January 26, 2023
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMTAlexandros Spyridonidis, Myriam Labopin, Bipin Savani, et al.
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
British Journal of Haematology|September 10, 2019
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT studyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Bone Marrow Transplantation|January 21, 2023
Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMTAnna Waszczuk-Gajda, Luuk Gras, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation|January 14, 2018
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMTSimone Cesaro, Roberto Crocchiolo, Gloria Tridello, et al.
Bone Marrow Transplantation|March 20, 2024
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTRomain Guièze, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|February 16, 2022
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMTJoanna Drozd-Sokołowska, Luuk Gras, Nienke Zinger, et al.
Pageof 12